Rajiv Amin
Plus aucun poste en cours
Fortune : - $ au 31/03/2024
Profil
Rajiv Amin worked as a Senior Director of Financial Reporting at Alvogen, Inc. and Kyowa Kirin, Inc. He also worked as a Controller-Americas at Convatec Group Plc.
Amin received his undergraduate degree from the University of Scranton and his graduate degree from Babson College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/03/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Anciens postes connus de Rajiv Amin
| Sociétés | Poste | Fin |
|---|---|---|
Alvogen, Inc.
 Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Corporate Officer/Principal | - |
| Kyowa Kirin, Inc. | Corporate Officer/Principal | - |
| CONVATEC GROUP PLC | Corporate Officer/Principal | - |
| IPI LEGACY LIQUIDATION CO | Directeur Financier/CFO | 10/05/2023 |
Formation de Rajiv Amin
| Babson College | Graduate Degree |
| University of Scranton | Undergraduate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IPI LEGACY LIQUIDATION CO | Health Technology |
| CONVATEC GROUP PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Kyowa Kirin, Inc. | |
Alvogen, Inc.
Alvogen, Inc. Pharmaceuticals: MajorHealth Technology Alvogen, Inc. develops, manufactures, and distributes generic pharmaceutical products. The firm's business include product development, contract manufacturing and research, sales of generic medicines, bio-similar, and over the counters. Its product portfolio consists of molecules for the treatment of conditions in the fields of oncology, cardiology, respiratory, neurology and gastroenterology. The company was founded by Robert Wessman in 2009 and is headquartered in Pine Brook, NJ. | Health Technology |
